Cargando…
Effect of Sulodexide on Urinary Biomarkers of Kidney Injury in Normoalbuminuric Type 2 Diabetes: A Randomized Controlled Trial
Glycosaminoglycans or sulodexide has shown benefits in early experimental diabetic nephropathy (DN) models, but its efficacy in patients with early stage of DN is unknown. Methods. Twenty patients were randomly assigned to the placebo group and another 20 patients were randomly assigned to receive s...
Autores principales: | Satirapoj, Bancha, Kaewput, Wisit, Supasyndh, Ouppatham, Ruangkanchanasetr, Prajej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396730/ https://www.ncbi.nlm.nih.gov/pubmed/25918727 http://dx.doi.org/10.1155/2015/172038 |
Ejemplares similares
-
Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
por: Yongwatana, Kachonsak, et al.
Publicado: (2020) -
Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study
por: Singhsakul, Amol, et al.
Publicado: (2019) -
Urinary angiotensinogen as a potential biomarker of diabetic nephropathy
por: Satirapoj, Bancha, et al.
Publicado: (2014) -
Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus
por: Satirapoj, Bancha, et al.
Publicado: (2015) -
Effect of Oral carnosine supplementation on urinary TGF-β in diabetic nephropathy: a randomized controlled trial
por: Siriwattanasit, Narongrit, et al.
Publicado: (2021)